400 related articles for article (PubMed ID: 32505564)
1. Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time.
Messori A; Bartoli L; Trippoli S
Dig Liver Dis; 2020 Oct; 52(10):1208-1209. PubMed ID: 32505564
[No Abstract] [Full Text] [Related]
2. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with NAB
Woodford R; Brungs D; Leighton C; Grimison P; Sjoquist KM; Becker T; Robinson S; Gebski V; Wilson K; Chantrill L; Aghmesheh M
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e220-e226. PubMed ID: 34180586
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100334. PubMed ID: 33592563
[TBL] [Abstract][Full Text] [Related]
5. A step forward in the treatment of advanced biliary tract cancer.
Wolpin BM; Mayer RJ
N Engl J Med; 2010 Apr; 362(14):1335-7. PubMed ID: 20375411
[No Abstract] [Full Text] [Related]
6. Role of chemotherapy in treatments for biliary tract cancer.
Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
[TBL] [Abstract][Full Text] [Related]
7. [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].
Nakamura N; Teramoto K; Arii S
Nihon Rinsho; 2006 Jan; 64 Suppl 1():534-8. PubMed ID: 16457320
[No Abstract] [Full Text] [Related]
8. Chemotherapy in biliary tract carcinomas: results in India.
Doval DC; Sekhon JS; Gupta SK; Gupta S; Awasthy BS
Semin Oncol; 2002 Dec; 29(6 Suppl 20):46-50. PubMed ID: 12577233
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for biliary tract cancer in Japan.
Okusaka T
Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
[TBL] [Abstract][Full Text] [Related]
10. A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer.
Yamanaka K; Hatano E; Kanai M; Tanaka S; Yamamoto K; Narita M; Nagata H; Ishii T; Machimoto T; Taura K; Uemoto S
Int J Clin Oncol; 2014; 19(3):485-9. PubMed ID: 23765238
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
Ann Surg; 2009 Dec; 250(6):950-6. PubMed ID: 19953713
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
Konishi M
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW
Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
[TBL] [Abstract][Full Text] [Related]
17. Review of gemcitabine in biliary tract carcinoma.
Scheithauer W
Semin Oncol; 2002 Dec; 29(6 Suppl 20):40-5. PubMed ID: 12577232
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine alone or in combination with Cisplatin for advanced biliary tract carcinomas: an overview of clinical evidence.
Sun TT; Wang JL; Fang JY
Asian Pac J Cancer Prev; 2013; 14(2):877-83. PubMed ID: 23621255
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers.
Jensen LH; Andersen RF; Byriel L; Fernebro E; Jakobsen A; Lindebjerg J; Nottelmann L; Ploen J; Hansen TF
Acta Oncol; 2020 Mar; 59(3):298-301. PubMed ID: 31838939
[No Abstract] [Full Text] [Related]
20. Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.
Edeline J; Benabdelghani M; Bertaut A; Watelet J; Hammel P; Joly JP; Boudjema K; Fartoux L; Bouhier-Leporrier K; Jouve JL; Faroux R; Guerin-Meyer V; Kurtz JE; Assénat E; Seitz JF; Baumgaertner I; Tougeron D; de la Fouchardière C; Lombard-Bohas C; Boucher E; Stanbury T; Louvet C; Malka D; Phelip JM
J Clin Oncol; 2019 Mar; 37(8):658-667. PubMed ID: 30707660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]